Targeting Upr mechanism by dasatinib as a promising therapeutic approach in chronic myeloid leukemia

Basit Öğe Kaydı
dc.contributor.authorOzel, B.
dc.contributor.authorKipcak, S.
dc.contributor.authorAvci, C. Biray
dc.contributor.authorGunduz, C.
dc.contributor.authorGunel, N. Selvi
dc.date.accessioned2019-10-27T11:05:46Z
dc.date.available2019-10-27T11:05:46Z
dc.date.issued2017
dc.departmentEge Üniversitesien_US
dc.description42nd Congress of the Federation-of-European-Biochemical-Societies (FEBS) on From Molecules to Cells and Back -- SEP 10-14, 2017 -- Jerusalem, ISRAELen_US
dc.description.sponsorshipFederat European Biochem Socen_US
dc.identifier.endpage272en_US
dc.identifier.issn1742-464X
dc.identifier.issn1742-4658
dc.identifier.startpage272en_US
dc.identifier.urihttps://hdl.handle.net/11454/31731
dc.identifier.volume284en_US
dc.identifier.wosWOS:000409918903219en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofFebs Journalen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleTargeting Upr mechanism by dasatinib as a promising therapeutic approach in chronic myeloid leukemiaen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu